Ultra-sensitive measurement technique shows how biomolecular motors carry out essential tasks

In the human body, hundreds of different types of biomolecular motors help carry out such essential tasks as muscle contraction, moving chromosomes during cell division, and reloading nerve cells so they can repeatedly fire.

How these little proteins perform their duties is becoming clearer to scientists using an extremely sensitive measurement technique. Myosin VI, they found, moves by the same “hand-over-hand” mechanism as two other molecular motors, myosin V and kinesin.

“Now that a third molecular motor has been found to move in the same hand-over-hand fashion, the argument for a rival ‘inchworm’ motion is getting pretty weak,” said Paul Selvin, a professor of physics at the University of Illinois at Urbana-Champaign and a co-author of a paper to appear in the Journal of Biological Chemistry.

Myosin VI is a reverse-direction molecular motor that moves materials to various locations within a living cell. Like the related protein myosin V, myosin VI has two “arms” connected to a “body.” The tiny molecule converts chemical energy into mechanical motion, and transports its load by “stepping” along polarized filaments of actin – but in the opposite direction from other myosin variants.

“Studies have suggested two main models for the stepping movement,” Selvin said. “One is the hand-over-hand model in which the two arms alternate in the lead. The other model is the inchworm model in which one arm always leads.”

To examine the myosin VI stepping mechanism, the researchers applied the same technique that was used to study both myosin V and kinesin. Called FIONA – Fluorescence Imaging with One Nanometer Accuracy – the measurement technique can track the position of a single molecule to within 1.5 nanometers. (One nanometer is a billionth of a meter, or about 10,000 times smaller than the width of a human hair).

“First, we attached a small fluorescent dye to one of the arms and took a picture with a digital camera attached to a microscope to find exactly where the dye was,” Selvin said. “Then we fed the myosin a little food called adenosine triphosphate, and it took a step. We took another picture, located the dye, and measured how far the dye moved.”

By examining the step size, the scientists could determine whether the protein used a hand-over-hand mechanism or an inchworm mechanism for movement. “The average step size for the myosin VI arm was approximately 60 nanometers, while the molecule’s center of mass moved only half that distance,” Selvin said. “This clearly indicated that a hand-over-hand model was being employed.”

Surprisingly, myosin VI has a step size that is highly variable, but on average is nearly as large as that of myosin V, which has a lever arm that is three times longer.

“For myosin VI to reach the same distance, the molecule must somehow come apart and then snap together again,” Selvin said. “To understand how it accomplishes this feat will require further study.”

The co-authors of the paper are Selvin, Hyokeun Park and Ahmet Yildiz at Illinois, and Li-Qiong Chen, Dan Safer, H. Lee Sweeney and Zhaohui Yang at the University of Pennsylvania. The National Institutes of Health funded the work.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Immunotherapy timing key to survival in small cell lung cancer treatment